Hjem › Kræft (alle typer) › Kansas
Kræft (alle typer) kliniske forsøg i Kansas
19 studier for Kræft (alle typer) søger deltagere på steder i Kansas.
Byer i Kansas
Officiel studietekst (engelsk)
A Study of ASP3082 in Adults With Advanced Solid Tumors
- University of Kansas Medical Center, Westwood
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT05382559Registry Study for Radiation Therapy Outcomes
- University of Kansas Proton Therapy Center, Kansas City
- Kansas City Proton Institute, Overland Park
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 29. sep. 2026 · NCT01255748A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- United Imaging Consultants, Lenexa
- MidAmerica Cancer Care- American Oncology Partners, Merriam
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- University of Kansas Cancer Center, Westwood
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06901531A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
- The University of Kansas Medical Center, Kansas City
Rekrutterer
Alder 15 til 24 · Alle køn · Opdateret 24. sep. 2026 · NCT07223463Prospective Study to Assess a Diagnostic Aid for Cancer
- Hutchinson Clinic, Hutchinson
RekruttererObservationsstudie
Alder 45 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07046260Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Kansas University Medical Center, Westwood
- Cancer Center of Kansas, Wichita
RekruttererFase 2/3
Alle aldre · Alle køn · Opdateret 18. sep. 2026 · NCT03435796RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- The University of Kansas Medical Center, Kansas City
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07002034A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- The University of Kansas Cancer Center, Westwood
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06634589A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The University of Kansas Cancer Center - Westwood, Westwood
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- University of Kansas, Westwood
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT06163534Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- AMR Kansas City Oncology, Kansas City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06072612Project: Every Child for Younger Patients With Cancer
- Wesley Medical Center, Wichita
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of Kansas Medical Center, Kansas City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT05335928A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Kansas Cancer Center, Kansas City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT05592626Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT06580314A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Fairway
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. jun. 2026 · NCT06431594A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- The University of Kansas Cancer Center, Westwood
RekruttererFase 1/2
Alder 18 til 70 · Alle køn · Opdateret 11. jun. 2026 · NCT05361174Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Kansas Hospital - Indian Creek Campus, Overland Park
- University of Kansas Hospital- Westwood Cancer Center, Westwood
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 27. nov. 2024 · NCT03860883Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.